Literature DB >> 27785950

Kinase-mediated signaling cascades in mood disorders and antidepressant treatment.

Li-Lian Yuan1, Eric Wauson1, Vanja Duric1.   

Abstract

Kinase-mediated signaling cascades regulate a number of different molecular mechanisms involved in cellular homeostasis, and are viewed as one of the most common intracellular processes that are robustly dysregulated in the pathophysiology of mood disorders such as depression. Newly emerged, rapid acting antidepressants are able to achieve therapeutic improvement, possibly in part, through stimulating activity of kinase-dependent signaling pathways. Thus, advancements in our understanding of how kinases may contribute to development and treatment of depression seem crucial. However, current investigations are limited to a single or small number of kinases and are unable to detect novel kinases. Here, we review fast developing kinome profiling approaches that allow identification of multiple kinases and kinase network connections simultaneously, analyze technical limitation and challenges, and discuss their future applications to mood disorders and antidepressant treatment.

Entities:  

Keywords:  Fast-acting antidepressant; kinase inhibitor; kinome profiling; major depressive disorders; protein kinase

Mesh:

Substances:

Year:  2016        PMID: 27785950      PMCID: PMC5590647          DOI: 10.1080/01677063.2016.1245303

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  48 in total

Review 1.  Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs.

Authors:  M Popoli; N Brunello; J Perez; G Racagni
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

Review 2.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

3.  A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

Authors:  Catharine H Duman; Lee Schlesinger; Masafumi Kodama; David S Russell; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

Review 4.  Microarray technologies for intracellular kinome analysis.

Authors:  T Yamamoto; T Mori; Y Katayama
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

Authors:  M Knockaert; N Gray; E Damiens; Y T Chang; P Grellier; K Grant; D Fergusson; J Mottram; M Soete; J F Dubremetz; K Le Roch; C Doerig; P Schultz; L Meijer
Journal:  Chem Biol       Date:  2000-06

Review 6.  Global discovery of protein kinases and other nucleotide-binding proteins by mass spectrometry.

Authors:  Yongsheng Xiao; Yinsheng Wang
Journal:  Mass Spectrom Rev       Date:  2014-11-05       Impact factor: 10.946

7.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

Review 8.  Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders.

Authors:  Eleonore Beurel
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

9.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.

Authors:  James S Duncan; Martin C Whittle; Kazuhiro Nakamura; Amy N Abell; Alicia A Midland; Jon S Zawistowski; Nancy L Johnson; Deborah A Granger; Nicole Vincent Jordan; David B Darr; Jerry Usary; Pei-Fen Kuan; David M Smalley; Ben Major; Xiaping He; Katherine A Hoadley; Bing Zhou; Norman E Sharpless; Charles M Perou; William Y Kim; Shawn M Gomez; Xin Chen; Jian Jin; Stephen V Frye; H Shelton Earp; Lee M Graves; Gary L Johnson
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

View more
  1 in total

Review 1.  Creatine for the Treatment of Depression.

Authors:  Brent M Kious; Douglas G Kondo; Perry F Renshaw
Journal:  Biomolecules       Date:  2019-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.